Creative Medical Technology Holdings Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Creative Medical Technology Holdings Inc.
- Former names
- Jolley Marketing Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Phoenix
- Headquarters state / province
- Arizona
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CELZ
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001187953
- EIN
- 87-0622284
Board of directors
-
Michael H. Finger · DirectorSince 2025
-
Timothy Warbington · Director · President & CEOSince 2023
Chief executives
Timothy Warbington
· President & CEO
Dates unknown
Director election results
Annual meeting of December 18, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
88.8%
-
91.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 24, 2026 | Timothy Warbington Director, Officer (President & CEO), 10% owner | Grant or award | +1,000,000 | — | — |
| Feb 19, 2025 | Michael H. Finger Director | Open-market sale | −750 | $5.75 | $4,313 |
| Feb 18, 2025 | Michael H. Finger Director | Open-market sale | −750 | $5.00 | $3,750 |
| Jun 28, 2023 | Timothy Warbington Director, Officer (President & CEO) | Open-market purchase | +200 | $4.36 | $872 |
| Jun 27, 2023 | Timothy Warbington Director, Officer (President & CEO) | Open-market purchase | +300 | $4.40 | $1,320 |
| Jun 27, 2023 | Timothy Warbington Director, Officer (President & CEO) | Open-market purchase | +300 | $4.45 | $1,335 |
| Jun 27, 2023 | Timothy Warbington Director, Officer (President & CEO) | Open-market purchase | +200 | $4.48 | $896 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.